Cargando…

Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis

Detalles Bibliográficos
Autores principales: Reuken, Philipp A., Torres, Dorian, Baier, Michael, Löffler, Bettina, Lübbert, Christoph, Lippmann, Norman, Stallmach, Andreas, Bruns, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305072/
https://www.ncbi.nlm.nih.gov/pubmed/28192501
http://dx.doi.org/10.1371/journal.pone.0172373
_version_ 1782506990377893888
author Reuken, Philipp A.
Torres, Dorian
Baier, Michael
Löffler, Bettina
Lübbert, Christoph
Lippmann, Norman
Stallmach, Andreas
Bruns, Tony
author_facet Reuken, Philipp A.
Torres, Dorian
Baier, Michael
Löffler, Bettina
Lübbert, Christoph
Lippmann, Norman
Stallmach, Andreas
Bruns, Tony
author_sort Reuken, Philipp A.
collection PubMed
description
format Online
Article
Text
id pubmed-5305072
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53050722017-02-28 Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis Reuken, Philipp A. Torres, Dorian Baier, Michael Löffler, Bettina Lübbert, Christoph Lippmann, Norman Stallmach, Andreas Bruns, Tony PLoS One Correction Public Library of Science 2017-02-13 /pmc/articles/PMC5305072/ /pubmed/28192501 http://dx.doi.org/10.1371/journal.pone.0172373 Text en © 2017 Reuken et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Reuken, Philipp A.
Torres, Dorian
Baier, Michael
Löffler, Bettina
Lübbert, Christoph
Lippmann, Norman
Stallmach, Andreas
Bruns, Tony
Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
title Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
title_full Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
title_fullStr Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
title_full_unstemmed Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
title_short Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis
title_sort correction: risk factors for multi-drug resistant pathogens and failure of empiric first-line therapy in acute cholangitis
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305072/
https://www.ncbi.nlm.nih.gov/pubmed/28192501
http://dx.doi.org/10.1371/journal.pone.0172373
work_keys_str_mv AT reukenphilippa correctionriskfactorsformultidrugresistantpathogensandfailureofempiricfirstlinetherapyinacutecholangitis
AT torresdorian correctionriskfactorsformultidrugresistantpathogensandfailureofempiricfirstlinetherapyinacutecholangitis
AT baiermichael correctionriskfactorsformultidrugresistantpathogensandfailureofempiricfirstlinetherapyinacutecholangitis
AT lofflerbettina correctionriskfactorsformultidrugresistantpathogensandfailureofempiricfirstlinetherapyinacutecholangitis
AT lubbertchristoph correctionriskfactorsformultidrugresistantpathogensandfailureofempiricfirstlinetherapyinacutecholangitis
AT lippmannnorman correctionriskfactorsformultidrugresistantpathogensandfailureofempiricfirstlinetherapyinacutecholangitis
AT stallmachandreas correctionriskfactorsformultidrugresistantpathogensandfailureofempiricfirstlinetherapyinacutecholangitis
AT brunstony correctionriskfactorsformultidrugresistantpathogensandfailureofempiricfirstlinetherapyinacutecholangitis